COSMO Pharmaceuticals SA (COPN) — Strategic Asset Allocation Index
COSMO Pharmaceuticals SA (COPN) has a Strategic Asset Allocation Index of 6.3% as of December 2025. Strategic assets (PP&E of CHF30.81 Million plus long-term investments of CHF-) total CHF30.81 Million, measured against net assets of CHF488.80 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of COSMO Pharmaceuticals SA to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
COSMO Pharmaceuticals SA Strategic Asset Allocation Index (2013–2025)
This chart shows how COSMO Pharmaceuticals SA's Strategic Asset Allocation Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 6.3%, representing strategic assets of CHF30.81 Million against net assets of CHF488.80 Million CHF. See COSMO Pharmaceuticals SA free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for COSMO Pharmaceuticals SA (2013–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for COSMO Pharmaceuticals SA from 2013 to 2025, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of COSMO Pharmaceuticals SA.
| Year | SAAI | Strategic Assets (CHF) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.3% | CHF30.81 Million | CHF30.81 Million | CHF- | CHF488.80 Million | ▲ +0.5 pp |
| 2024 | 5.8% | CHF29.09 Million | CHF29.09 Million | CHF- | CHF505.09 Million | ▼ -0.9 pp |
| 2023 | 6.7% | CHF28.59 Million | CHF28.59 Million | CHF- | CHF429.04 Million | ▲ +0.1 pp |
| 2022 | 6.5% | CHF30.28 Million | CHF30.28 Million | CHF- | CHF463.79 Million | ▲ +0.6 pp |
| 2021 | 5.9% | CHF30.48 Million | CHF30.48 Million | CHF- | CHF512.68 Million | ▼ -1.4 pp |
| 2020 | 7.3% | CHF29.30 Million | CHF29.30 Million | CHF- | CHF400.12 Million | ▼ -0.3 pp |
| 2019 | 7.7% | CHF30.19 Million | CHF30.19 Million | CHF- | CHF393.73 Million | ▼ -37.5 pp |
| 2018 | 45.2% | CHF200.87 Million | CHF28.62 Million | CHF172.26 Million | CHF444.85 Million | ▼ -10.1 pp |
| 2017 | 55.2% | CHF259.70 Million | CHF30.15 Million | CHF229.55 Million | CHF470.12 Million | ▼ -1.1 pp |
| 2016 | 56.4% | CHF234.17 Million | CHF20.67 Million | CHF213.50 Million | CHF415.56 Million | ▼ -16.3 pp |
| 2015 | 72.7% | CHF293.35 Million | CHF21.13 Million | CHF272.22 Million | CHF403.65 Million | ▼ -20.7 pp |
| 2014 | 93.4% | CHF142.27 Million | CHF21.45 Million | CHF120.83 Million | CHF152.29 Million | ▲ +86.2 pp |
| 2013 | 7.3% | CHF16.00 Million | CHF- | CHF16.00 Million | CHF220.16 Million | — |